Sectors

DXCM
DexCom, Inc.
69.75
2 x 65.24
2 x 75.64
bid
ask
+
0.83
1.20%
2 @ 04:29 PM
69.46 -0.29 (0.42%)
Ytd 5.09%
1y -20.35%
68.92
day range
71.08
54.11
52 week range
89.98
Open 69.00 Prev Close 68.92 Low 68.92 High 71.08 Mkt Cap 26.91B
Vol 3.79M Avg Vol 5.53M EPS 2.33 P/E 29.94 Forward P/E 22.36
Beta 1.44 Short Ratio 2.38 Inst. Own 102.46% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 07-29 50-d Avg 66.77 200-d Avg 67.41 1yr Est 85.21
Earning
Date For Estimate Reported Surprise surprise %
2026-04-30 2026-03 0.47 0.56 0.09 19.15%
2026-02-12 2025-12 0.65 0.68 0.03 4.62%
2025-10-30 2025-09 0.57 0.61 0.04 7.02%
2025-07-30 2025-06 0.45 0.48 0.03 6.67%
2025-05-01 2025-03 0.33 0.32 -0.01 -3.03%
2025-02-13 2024-12 0.5 0.45 -0.05 -10.00%
Upgrade / Downgrade
Date Firm Action From To
2026-06-23 Deutsche Bank Upgrade Buy Buy
2026-06-15 Piper Sandler Upgrade Overweight Overweight
2026-06-10 TD Cowen Upgrade Buy Buy
2026-06-09 Mizuho Upgrade Outperform Outperform
2026-06-05 Stifel Upgrade Buy Buy
2026-05-28 Citigroup Upgrade Buy Buy
Profile
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Insider Holder
Date Name Relation Quantity Description
2026-05-27 ALTMAN STEVEN R Director 69.23K Stock Award(Grant)
2026-06-14 BROWN MICHAEL JON Officer 106.35K Sale
2026-06-03 COLEMAN JON Officer 95.45K Sale
2026-05-27 COLLINS RICHARD ALEXANDER Director 45.77K Stock Award(Grant)
2026-06-14 FOLETTA MARK G Director 0.00 Sale
2026-03-05 LEACH JACOB STEVEN Chief Executive Officer 469.11K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 38.96M 2.72B 10.10%
2026-03-30 Vanguard Capital Management LLC 25.02M 1.74B 6.48%
2026-03-30 Vanguard Portfolio Management LLC 19.22M 1.34B 4.98%
2026-03-30 State Street Corporation 17.93M 1.25B 4.65%
2026-03-30 BAILLIE GIFFORD & CO 15.60M 1.09B 4.04%
2026-03-30 Alliancebernstein L.P. 12.92M 901.17M 3.35%
Fund Ownership
Report Date Organization Position Value Percentage
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 12.22M 852.24M 3.17%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 9.78M 681.92M 2.53%
2026-05-30 Invesco QQQ Trust, Series 1 8.36M 582.94M 2.17%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 8.31M 579.57M 2.15%
2026-04-29 iShares Trust-iShares Core S&P 500 ETF 4.98M 347.12M 1.29%
2026-04-29 Fidelity Concord Street Trust-Fidelity 500 Index Fund 4.93M 343.91M 1.28%
Split
Split Date
4 : 1 2022-06-13
4 : 1 2022-06-10